Your browser doesn't support javascript.
loading
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Vaugier, Loig; Palpacuer, Clément; Rio, Emmanuel; Goineau, Aurore; Pasquier, David; Buthaud, Xavier; De Laroche, Guy; Beckendorf, Véronique; Sargos, Paul; Créhange, Gilles; Pommier, Pascal; Loos, Geneviève; Hasbini, Ali; Latorzeff, Igor; Silva, Marlon; Denis, Fabrice; Lagrange, Jean-Léon; Campion, Loic; Supiot, Stéphane.
Afiliação
  • Vaugier L; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France.
  • Palpacuer C; Department of Biostatistics, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, Nantes, St-Herblain, France.
  • Rio E; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France.
  • Goineau A; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France.
  • Pasquier D; Academic Radiation Oncology Department, Centre Oscar Lambret, Lille, France; Centre de Recherche en Informatique, Signal et Automatique de Lille, CRIStAL UMR CNRS 9189, Université de Lille, Lille, France.
  • Buthaud X; Department of Radiation Oncology, Centre Catherine de Sienne, Nantes, France.
  • De Laroche G; Department of Radiation Oncology, Institut de Cancérologie de la Loire, St Priest en Jarez, France.
  • Beckendorf V; Department of Radiation Oncology, Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France.
  • Sargos P; Department of Radiation Oncology, Institut Bergonié, Bordeaux, France.
  • Créhange G; Department of Radiation Oncology, Georges-Francois Leclerc Cancer Center, Dijon, France.
  • Pommier P; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
  • Loos G; Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • Hasbini A; Department of Radiation Oncology, Clinique Pasteur, Brest, France.
  • Latorzeff I; Department of Radiation Oncology, Oncorad Clinique Pasteur, Toulouse, France.
  • Silva M; Department of Radiation Oncology, Centre Francois Baclesse, Caen, France.
  • Denis F; Department of Radiation Oncology, Centre Jean Bernard, Le Mans, France.
  • Lagrange JL; Department of Radiation Oncology, Hopital Henri Mondor, Créteil, France.
  • Campion L; Department of Biostatistics, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, Nantes, St-Herblain, France; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), UMR 1232 Inserm - 6299 CNRS, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France.
  • Supiot S; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), UMR 1232 Inserm - 6299 CNRS, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France. Electronic address: stephane.supiot@ic
Int J Radiat Oncol Biol Phys ; 103(5): 1061-1067, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30557672

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Irradiação Linfática / Terapia de Salvação / Antagonistas de Androgênios / Linfonodos Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Aged / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Irradiação Linfática / Terapia de Salvação / Antagonistas de Androgênios / Linfonodos Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Aged / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França